PDCD1 and gestational trophoblastic neoplasm: Recent studies revealed a promising effect of the PD-1 inhibitor by pembrolizumab as a novel solution for management of the targeting patients by reporting a series of cases with chemotherapy-resistant GTN (4, 6–9).